idarubicin - CISMeF

Preferred Label : idarubicin;

MeSH definition : An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA.;

MeSH synonym : 4 desmethoxydaunorubicin; 4-demethoxydaunorubicin; 4-desmethoxydaunorubicin; 4 demethoxydaunorubicin;

MeSH hyponym : idarubicin hydrochloride; NSC-256439; IMI-30; IMI 30; IMI30; NSC 256439; NSC256439; Hydrochloride, Idarubicin;

MeSH CAS label : 5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-;

MeSH Related Number : idarubicin hydrochloride; 57852-57-0 (Idarubicin hydrochloride); 58957-92-9 (Idarubicin); 5VV3MDU5IE;

Registry Number MeSH : 58957-92-9;

Related CAS MeSH : 5VV3MDU5IE (Idarubicin hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Idarubicin;

Is substance : O;

UNII : ZRP63D75JW;

InChIKey : XDXDZDZNSLXDNA-TZNDIEGXSA-N;

Details

Origin ID

D015255;

UMLS CUI

C0020789;

ATC code(s)
- idarubicin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Idarubicin adverse reaction (disorder) [SNOMED CT concept]
- Idarubicin poisoning (disorder) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Idarubicin [ICD-11 Extension code]
- Idarubicin [ICHI extension code]
- Idarubicin [SMS substance]
- Idarubicin [NCIt concept]
- Idarubicin (substance) [SNOMED CT concept]
Pharmacological action(s)
- antibiotics, antineoplastic [MeSH Descriptor]
- enzyme inhibitors [MeSH Descriptor]
- topoisomerase II inhibitors [MeSH Descriptor]
Record concept(s)
- IMI-30 [MeSH concept]
- NSC-256439 [MeSH concept]
- idarubicin [MeSH concept]
- idarubicin hydrochloride [MeSH concept]
Related MeSH Supplementary Concept(s)
- 13-methyl-13-dihydro-4-demethoxydaunorubicin [MeSH Supplementary Concept]
- 4-demethoxy-10,10-dimethyldaunomycin [MeSH Supplementary Concept]
- 4-demethoxy-11-deoxydaunomycin [MeSH Supplementary Concept]
- 4-demethoxydaunomycinone [MeSH Supplementary Concept]
- 4-demethoxydaunorubicin bis(hydrazone) [MeSH Supplementary Concept]
- 8-fluoroidarubicin [MeSH Supplementary Concept]
- 8-hydroxy-8-methylidarubicinone [MeSH Supplementary Concept]
- 9-O-daunosaminyl-4-demethoxydaunorubicin [MeSH Supplementary Concept]
- AIDA protocol [MeSH Supplementary Concept]
- ALL-1 protocol [MeSH Supplementary Concept]
- CIOD protocol [MeSH Supplementary Concept]
- CIOP protocol [MeSH Supplementary Concept]
- CIOP-Bleo protocol [MeSH Supplementary Concept]
- CIP protocol [MeSH Supplementary Concept]
- DIZE protocol [MeSH Supplementary Concept]
- EORTC GIMEMA AML-10 protocol [MeSH Supplementary Concept]
- EORTC GIMEMA AML-13 protocol [MeSH Supplementary Concept]
- ETI protocol [MeSH Supplementary Concept]
- FLIDA protocol [MeSH Supplementary Concept]
- FLU-ID regimen [MeSH Supplementary Concept]
- GIMEMA ALL 0394 [MeSH Supplementary Concept]
- ICBV regimen [MeSH Supplementary Concept]
- ICE protocol 4 [MeSH Supplementary Concept]
- IIVP-16 [MeSH Supplementary Concept]
- IVAP protocol [MeSH Supplementary Concept]
- Ida-FLAG protocol [MeSH Supplementary Concept]
- LAI regimen [MeSH Supplementary Concept]
- MATILDE regimen [MeSH Supplementary Concept]
- MIZE protocol [MeSH Supplementary Concept]
- TCID protocol [MeSH Supplementary Concept]
- VICED protocol [MeSH Supplementary Concept]
- VICOP-B protocol [MeSH Supplementary Concept]
- VID protocol [MeSH Supplementary Concept]
- idarubicinone [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Idarubicin [ICD-11 Extension code]
- Idarubicin [NCIt concept]
- Idarubicin (substance) [SNOMED CT concept]
- Product containing idarubicin (medicinal product) [SNOMED CT concept]
- idarubicin [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients